Ensysce Biosciences Inc [NASDAQ: ENSC] stock went on an upward path that rose over 0.48% on Thursday, amounting to a one-week price decrease of less than -5.00%.
Over the last 12 months, ENSC stock dropped by -74.32%. The one-year Ensysce Biosciences Inc stock forecast points to a potential upside of 88.67. The average equity rating for ENSC stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $4.95 million, with 2.37 million shares outstanding and 2.33 million shares in the current float. Compared to the average trading volume of 205.13K shares, ENSC stock reached a trading volume of 14937404 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ensysce Biosciences Inc [ENSC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENSC shares is $18.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENSC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 1.13, with the Price to Cash per share for the same quarter was set at 1.29.
ENSC Stock Performance Analysis:
Ensysce Biosciences Inc [ENSC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.00. With this latest performance, ENSC shares dropped by -6.70% in over the last four-week period, additionally sinking by -69.84% over the last 6 months – not to mention a drop of -74.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENSC stock in for the last two-week period is set at 43.12, with the RSI for the last a single of trading hit 0.18, and the three-weeks RSI is set at 0.18 for Ensysce Biosciences Inc [ENSC]. The present Moving Average for the last 50 days of trading for this stock 2.20, while it was recorded at 2.18 for the last single week of trading, and 4.77 for the last 200 days.
Insight into Ensysce Biosciences Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Ensysce Biosciences Inc [ENSC] shares currently have an operating margin of -110.13%. Ensysce Biosciences Inc’s Net Margin is presently recorded at -109.51%.
Ensysce Biosciences Inc (ENSC) Capital Structure & Debt Analysis
According to recent financial data for Ensysce Biosciences Inc. ( ENSC), the Return on Equity (ROE) stands at -200.53%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -140.74%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Ensysce Biosciences Inc’s Return on Invested Capital (ROIC) is -223.55%, showcasing its effectiveness in deploying capital for earnings.
Ensysce Biosciences Inc (ENSC) Efficiency & Liquidity Metrics
Based on Ensysce Biosciences Inc’s (ENSC) latest financial statements, the Debt-to-Equity Ratio is 0.08%, indicating its reliance on debt financing relative to shareholder equity.
Ensysce Biosciences Inc (ENSC) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Ensysce Biosciences Inc. (ENSC) effectively leverages its workforce, generating an average of -$757777.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.50% and a Quick Ratio of 2.50%, indicating strong ability to cover short-term liabilities.
Ensysce Biosciences Inc [ENSC] Institutonal Ownership Details
There are presently around $14.91%, or 14.98%% of ENSC stock, in the hands of institutional investors.
